Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A structure-activity relationship (SAR) translation strategy was used for the discovery of tetrahydroisoquinoline (THIQ)-based steroidomimetic and chimeric microtubule disruptors based upon a steroidal starting point. A steroid A,B-ring-mimicking THIQ core was connected to methoxyaryl D-ring ring mimics through methylene, carbonyl and sulfonyl linkers to afford a number of steroidomimetic hits (e.g., 7-methoxy-2-(3- methoxybenzyl)-6-sulfamoyloxy-1,2,3,4-tetrahydroisoquinoline (20 c) GI₅₀=2.1 μM). Optimisation and control experiments demonstrate the complementary SAR of this series and the steroid derivatives that inspired its design. Linkage of the THIQ-based A,B-mimic with the trimethoxyaryl motif prevalent in colchicine site binding microtubule disruptors delivered a series of chimeric molecules whose activity (GI₅₀=40 nM) surpasses that of the parent steroid derivatives. Validation of this strategy was obtained from the excellent oral activity of 7-methoxy-6-sulfamoyloxy-2-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinoline relative to a benchmark steroidal bis- sulfamate in an in vivo model of multiple myeloma.

Original publication

DOI

10.1002/cmdc.201300261

Type

Journal article

Journal

ChemMedChem

Publication Date

01/2014

Volume

9

Pages

85 - 1

Keywords

colchicine binding, microtubule disruptors, tetrahydroisoquinolines, tubulin assembly, Animals, Antineoplastic Agents, Benzyl Compounds, Cell Line, Tumor, Cell Proliferation, Humans, Isoquinolines, Mice, Mice, Nude, Microtubules, Multiple Myeloma, Stereoisomerism, Structure-Activity Relationship, Tetrahydroisoquinolines, Transplantation, Heterologous, Tubulin Modulators